SYSTEM, APPENDAGE CLOSURE, LEFT ATRIAL
Report
- Report Number
- 2124215-2025-46114
- Event Type
- Injury
- Date Received
- July 15, 2025
- Date of Event
- November 19, 2024
- Report Date
- July 15, 2025
- Manufacturer
- BOSTON SCIENTIFIC CORPORATION
- Product Code
- NGV
- Adverse Event
- Yes
- Report Source
- Manufacturer report
- Reporter Location
- IT
- Reporter Occupation
- PHYSICIAN
- Health Professional
- Yes
Narratives
B3 DATE OF EVENT - ARTICLE PUBLISH DATE USED AS EVENT DATE IS UNKNOWN. D4 MODEL NUMBER, D4 LOT NUMBER, D4 EXPIRATION DATE, D4 UNIQUE IDENTIFIER (UDI) # ARE UNKNOWN AS THE INFORMATION WAS NOT PROVIDED IN THE LITERATURE ARTICLE. D6A IMPLANT DATE WAS REPORTED AS BETWEEN (B)(6) 2021 AND (B)(6) 2023.
REPORTED VIA JOURNAL ARTICLE. IT WAS REPORTED THAT THERE WAS A THROMBUS. THIS STUDY WAS AIMED AT ASSESSING 1 YEAR CLINICAL AND TRANSESOPHAGEAL ECHOCARDIOGRAPHIC (TEE) OUTCOMES IN A CONSECUTIVE SERIES OF PATIENTS UNDERGOING LEFT ATRIAL APPENDAGE (LAA) CLOSURE WITH A SINGLE-SEAL (WATCHMAN FIRST GENERATION OR WATCHMAN FLX) OR DUAL- SEAL DEVICE (NON-BOSTON SCIENTIFIC DEVICE). RESULTS: BETWEEN JANUARY 2021 AND JANUARY 2023 47 PATIENTS WERE ENROLLED, WITH PAROXYSMAL, PERSISTENT OR PERMANENT NON VALVULAR ATRIAL FIBRILLATION, A CHA2DS2-VASC SCORE OF 3 AND A HAS-BLED SCORE OF 3, NOT ELIGIBLE FOR LONG-TERM ORAL ANTICOAGULATION. AT ONE (1) YEAR FOLLOW-UP, NO PATIENT REPORTED CLINICAL EVENTS. AT ONE (1) YEAR FOLLOW UP TEE, 1 PATIENT EXHIBITED A PERI-DEVICE LEAK LESS THAN 3MM, WITHOUT ANY CLINICAL EVENT. TWO PATIENTS EXHIBITED DEVICE- RELATED THROMBOSIS (1 WATCHMAN AND 1 NON-BOSTON SCIENT DEVICE). THESE PATIENTS UNDERWENT LONG-TERM IMAGING SURVEILLANCE.
Devices
| Seq | Brand | Generic | Product Code | Manufacturer | Model | Lot | UDI-DI |
|---|---|---|---|---|---|---|---|
| 1572750 | SYSTEM, APPENDAGE CLOSURE, LEFT ATRIAL | NGV | BOSTON SCIENTIFIC CORPORATION |
Patients
| Seq | Age | Sex | Outcome | Treatment |
|---|---|---|---|---|
| 1 | NA | Unknown | Other |